placeNew Zealand


BIS™ monitoring to help improve anaesthesia-related outcomes

With the BISx™ OEM module from Medtronic, BIS™ brain monitoring technology can be easily integrated into medical devices in a wide range of healthcare settings—from acute care monitors in operating rooms and intensive care units to preconfigured devices in ambulatory surgery centers or procedural sedation locations.

When you integrate the BISx™ OEM module into your anaesthesia and sedation monitoring systems, you can offer your customers the industry’s most widely studied and published level of consciousness monitoring parameter. BIS™ technology can provide insight into the direct and patient-specific effects of anaesthesia on the brain to improving perioperative outcomes1.


BIS™ brain monitoring technology advantages

Based on the scientifically validated BIS™ algorithm, BIS™ brain monitoring technology uses innovative technology to link patient-specific EEG information to the individual clinical state of each patient.

Clinical benefits of BIS™ brain monitoring technology

Anaesthesia-related clinical benefits include:

  • Up to 23% decrease in anaesthetic drug use([FOOTNOTE=Gan TJ, Glass PS, Windsor A, et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS™ Utility Study Group. Anesthesiology. 1997;87:808-815. (No funding or sponsorship provided by Medtronic for this study)],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=35754])
  • Up to 40% faster wake-up time1
  • Faster recovery and extubation times([FOOTNOTE=Punjasawadwong Y, Boonjeungmonkol N, Phongchiewboon A. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database of Systematic Reviews. 2007;17(4):CD003843. (No funding or sponsorship provided by Medtronic for this study)],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=185841])
  • 87% increase in “excellent/fully oriented” status on PACU admission1
  • 32% faster eligibility for PACU discharge([FOOTNOTE=White PF, Ma H, Tang J, et al. Does the use of electroencephalographic bispectral index or auditory evoked potential index monitoring facilitate recovery after desflurane anesthesia in the ambulatory setting? Anesthesiology. 2004;100:811-817. (No funding or sponsorship provided by Medtronic for this study)],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=35731])
  • 80% lower incidence of intraoperative([FOOTNOTE=Myles PS, Leslie K, McNeil J, et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomized controlled trial. Lancet. 2004;363:1757-1763. (Some unrestricted funding for this study was provided by Aspect Medical Systems (Newton, MA, USA). )],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=35729]),([FOOTNOTE=Avidan MS, et al. Anesthesia awareness and the bispectral index. N Engl J Med. 2008;13;358(11):1097-1108. (No funding or sponsorship provided by Medtronic for this study)],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=185918]),([FOOTNOTE=Avidan MS, et al. Prevention of intraoperative awareness in a high-risk surgical population. N Engl J Med. 2011;18;365(7):591-600. (No funding or sponsorship provided by Medtronic for this study)],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=301466]),([FOOTNOTE=Ekman A, Lindholm ML, Lennmarken C, et al. Reduction in the incidence of awareness using BIS™ monitoring. Acta Anaesthesiol Scand. 2004;48:20-26. (This study was supported by a grant from Aspect Medical Systems, MA - now Covidien / Medtronic)],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=117525]) awareness with recall in adults
  • Improved patient satisfaction([FOOTNOTE=Luginbuhl M, Wuthrich S, Petersen-Felix S, et al. Different benefits of bispectral index (BIS™) in desflurane and propofol anesthesia. Acta Anaesthesiol Scand. 2003;47:165-173. (No funding or sponsorship provided by Medtronic for this study)],[ANCHOR=],[LINK=/content/mitg/websites/languagemasters/na/en-us/support/clinical-evidence.html?id=35736])